RedHill Biopharma (RDHL) Interest Coverage Ratio (2012 - 2023)

RedHill Biopharma (RDHL) has 12 years of Interest Coverage Ratio data on file, last reported at 27.91 in Q2 2023.

• On a quarterly basis, Interest Coverage Ratio rose 1184.06% year-over-year to 27.91 in Q2 2023; TTM through Jun 2023 was 1.2, a 94.48% increase from a year earlier, with the FY2025 full-year figure at 5.45, down 27.37% from the prior year.
• Interest Coverage Ratio for Q2 2023 stood at 27.91, up from 69.07 in the prior quarter.
• Over the last five years, Interest Coverage Ratio for RDHL reached as high as 62.91 in Q4 2019 and fell as low as 69.07 in Q1 2023.
• Historically, Interest Coverage Ratio has averaged 1.38 across 5 years, with a median of 3.62 in 2020.
• Across the five-year window, Interest Coverage Ratio surged 1380.98% in 2019 and plunged 1723.72% in 2023, its largest moves.
• Year by year, Interest Coverage Ratio stood at 62.91 in 2019, then sank by 114.42% to 9.07 in 2020, then jumped by 305.17% to 18.61 in 2021, then sank by 264.06% to 30.53 in 2022, then soared by 191.42% to 27.91 in 2023.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 27.91 in Q2 2023, 69.07 in Q1 2023, and 30.53 in Q4 2022.